China Greenlights CanSinos Clinical Trial for Tetanus Vaccine - Marketscreener.com
| CJH Stock | EUR 3.64 0.02 0.55% |
Roughly 54% of CanSino Biologics' investor base is interested to short. The analysis of current outlook of investing in CanSino Biologics suggests that many traders are impartial regarding CanSino Biologics' prospects. The current market sentiment, together with CanSino Biologics' historical and current headlines, can help investors time the market. In addition, many technical investors use CanSino Biologics stock news signals to limit their universe of possible portfolio assets.
CanSino Biologics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of CanSino daily returns and investor perception about the current price of CanSino Biologics as well as its diversification or hedging effects on your existing portfolios.
CanSino |
China Greenlights CanSinos Clinical Trial for Tetanus Vaccine Marketscreener.com
Read at news.google.com
 |
CanSino Biologics Fundamental Analysis
We analyze CanSino Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CanSino Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CanSino Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
CanSino Biologics is rated below average in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
CanSino Biologics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CanSino Biologics stock to make a market-neutral strategy. Peer analysis of CanSino Biologics could also be used in its relative valuation, which is a method of valuing CanSino Biologics by comparing valuation metrics with similar companies.
Peers
CanSino Biologics Related Equities
| LDZU | ASPEN PHARUNADR | 4.68 | ||||
| TSUA | Tsumura | 0.00 | ||||
| CJH | CanSino Biologics | 0.55 | ||||
| TKDA | Takeda Pharmaceutical | 0.81 | ||||
| GU5 | Guangzhou Baiyunshan | 0.93 | ||||
| MRK | Merck | 1.16 | ||||
| HPX | Hisamitsu Pharmaceutical | 1.59 | ||||
| 5EA | Elanco Animal | 1.60 | ||||
| 3KY | HANSOH PHARMAC | 2.70 |
Complementary Tools for CanSino Stock analysis
When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |